APD Medical Sp. z o.o.

From training software to medical device

A Warsaw neuro-audiology company with an auditory training platform and a distributed provider network

Industry
Neuro-Audiology Digital Health
Headquarters
Warsaw, Poland
Public information as of
January 2026

A4BEE prepared this analysis from publicly available sources. It reflects our own reading of APD Medical Sp. z o.o.'s published strategy and is not endorsed by, or produced in cooperation with, APD Medical Sp. z o.o.. Company website

Strategic priorities

APD Medical Sp. z o.o. is a Polish digital health company specialising in Auditory Processing Disorder diagnosis and therapy through its Neuroflow Active Auditory Training platform. The platform delivers adaptive, interactive auditory training exercises grounded in the proprietary normative research of a co-founder, and serves children, adolescents, and adults across Poland through a network of independent speech therapists, audiologists, and psychologists. The company has operated since 2014, with two co-founders holding equal ownership.

The core strategic tension is the classification gap: Neuroflow ATS is currently categorised as a pedagogical tool rather than a medical device, which limits insurance reimbursement and healthcare system integration. Pursuing Software as a Medical Device certification under EU MDR would enable both reimbursement pathways and hospital IT integration — but requires clinical validation data, a quality management system, and FHIR-compliant architecture that the current platform does not have.

The distributed provider network creates a second challenge: independent providers use varying equipment quality and operate in different acoustic environments, which compromises the consistency of diagnostic data that feeds into the central AI platform. Without standardised hardware calibration and ambient environment monitoring, the longitudinal data used to train and validate the AI diagnostic algorithms has quality variance that limits the accuracy of the platform's claims.

Challenges we see

  • Operations Manufacturing

    Provider equipment inconsistency undermining diagnostic data quality

    The provider network includes independent speech therapists, audiologists, and psychologists operating with varying consumer-grade equipment and in different acoustic environments. Each provider's diagnostic hardware — headphones, microphones, and sound cards — introduces different calibration drift and frequency response characteristics into the data that is fed into the central Neuroflow platform.

    When the input data to the Neuroflow AI diagnostic algorithms comes from non-standardised hardware across providers, the platform's accuracy comparisons across patients and population groups are confounded by equipment variation — the proprietary normative database is only as reliable as the diagnostic equipment that generates the input data.

  • Compliance Regulatory

    Pedagogical classification limiting healthcare system integration

    Neuroflow ATS is currently classified as a pedagogical tool rather than a medical device — a deliberate choice to avoid EU MDR stringency, but one that prevents integration with hospital information systems, electronic health records, and insurance reimbursement workflows. The path to MDR certification requires clinical validation studies, a quality management system, and post-market surveillance infrastructure that the current platform lacks.

    As competing digital therapeutic platforms pursue and achieve medical device certification, APD Medical's pedagogical classification becomes a competitive disadvantage — clinicians and insurers increasingly expect digital therapeutics to be CE-marked medical devices, not educational software.

  • Digital Integration

    Audio stimulus accuracy not verified in consumer-grade headphone delivery

    The Neuroflow platform delivers auditory stimuli through consumer-grade headphones connected to provider computers. Without hardware-in-the-loop calibration verification, there is no guarantee that the decibel levels and frequency spectra of the delivered stimuli match the calibrated reference values encoded in the platform's diagnostic algorithms.

    When a therapeutic stimulus is delivered at an unintended intensity or frequency because of consumer headphone limitations, the patient's neural response recorded by the platform is measured against a diagnostic reference that does not correspond to what the patient actually heard — the diagnostic result is systematically biased by hardware inconsistency.

  • Operations Operations

    Brand collision with international NeuroFlow entities

    Several international entities use the NeuroFlow name — including a major US behavioural health platform with deep EHR integrations and AI-driven risk stratification. The shared brand creates market confusion risk and positions APD Medical against a better-resourced international competitor in any market where both are visible.

    International expansion requires a brand differentiation strategy that clearly positions APD Medical's neuro-audiology focus against the broader behavioural health positioning of the US entity — without clear differentiation, market entry investment may be diluted by brand confusion.

  • Digital Integration

    Patient data locked in disconnected provider systems

    Patient records and diagnostic data from provider-led assessments frequently remain in local systems, Excel spreadsheets, or disconnected clinical notes. The longitudinal patient data that the Neuroflow platform requires for predictive analytics and therapy personalisation is incomplete because it is trapped in provider silos.

    The machine learning models that power the platform's diagnostic and therapy adaptation capabilities are trained on data that reflects only what the platform has recorded — not the full clinical picture of the patient's developmental history, co-occurring conditions, and prior interventions that would make the AI predictions clinically useful.

Opportunities, by urgency and business impact

Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.

Source: A4BEE analysis of public sources
  1. Standardised IoT diagnostic hardware across the provider network

    Providers use consumer-grade headphones and audio equipment without automated calibration verification, creating diagnostic data quality variance that undermines the consistency of the Neuroflow platform's accuracy claims and limits the comparability of results across providers.

    Deploy certified IoT-enabled diagnostic hardware kits — calibrated headphones, measurement microphones, and audio interface verification — with cloud-synchronised calibration data so that every provider session includes a verified hardware calibration record, eliminating equipment-driven data quality variance.

    • Provider network equipment audit findings
    • Neuroflow platform diagnostic data quality assessment
  2. Provider network digital operating system for certification and referrals

    Training and certification of the provider network is delivered as discrete events without continuous competency monitoring. High-performing providers are not distinguished from low-performing ones, and patient referrals within the network happen by reputation rather than by data.

    Build a provider network digital operating system with automated certification tracking, AI-driven competency monitoring based on diagnostic accuracy patterns, and patient referral automation — transforming the network from a collection of independent practitioners into a data-driven clinical ecosystem.

    • APD Medical provider network engagement model
    • Neuroflow platform utilisation data across providers
  3. FHIR-compliant integration and SaMD certification pathway

    Without FHIR-compliant APIs and medical device certification, the Neuroflow platform cannot integrate with hospital EHR systems, participate in insurance reimbursement schemes, or be prescribed within clinical care pathways — limiting the addressable market to self-pay patients.

    Pursue Software as a Medical Device certification under EU MDR while building a FHIR-compliant integration architecture — enabling the hospital system integrations, EHR connectivity, and reimbursement pathways that the medical device classification enables.

    • EU MDR SaMD classification requirements for digital therapeutics
    • APD Medical regulatory strategy documentation
  4. Predictive diagnostic engine for early auditory processing disorder detection

    The platform currently uses normative comparisons for diagnosis — comparing a patient's results against population reference groups — but lacks machine learning capabilities to identify sub-clinical patterns or predict therapeutic outcomes before they manifest.

    Develop a predictive diagnostic engine using ML models trained on longitudinal patient data to identify auditory processing patterns that precede clinical disorder, enabling earlier intervention and personalised therapy intensity — the clinical capability that would differentiate Neuroflow from any competing platform.

    • Neuroflow platform longitudinal data availability
    • Machine learning capabilities for developmental disorder prediction
  5. Environmental monitoring for therapy session validity

    Home and clinic therapy sessions may be conducted in acoustic environments that compromise the validity of the auditory stimulus delivery — background noise, reverberation, and ambient sound levels are not measured or controlled, meaning that some therapy sessions produce unreliable neural response data.

    Integrate ambient noise sensors and biometric feedback wearables that synchronise with the therapy software to automatically flag or pause sessions when environmental conditions exceed the acoustic thresholds required for valid stimulus delivery — ensuring that every session in the longitudinal dataset meets the quality standard required for clinical validity.

    • Acoustic environment validation requirements for auditory training
    • Biometric integration feasibility for Neuroflow platform

What we'd propose

  • Digital Lab

    IoT-Enabled Diagnostic Hardware Standardisation Across Provider Network

    We deploy a certified IoT diagnostic hardware ecosystem across the APD Medical provider network — calibrated headphones, measurement microphones, and audio interface verification with cloud-synchronised calibration records — ensuring that every diagnostic session captures data with known, consistent hardware characteristics, and eliminating the equipment-driven variance that currently confounds the platform's normative comparisons.

    • IoT headset with embedded calibration verification

      Every headset calibrated and verified before each session

      Deploy Bluetooth-connected calibrated headphones with embedded calibration verification — a built-in tone generator and measurement microphone confirm that the delivered stimulus matches the platform's reference values within specified tolerances before every diagnostic session, with the verification record stored in the patient data record.

    • Cloud calibration registry for provider equipment

      Provider hardware status tracked and alerts issued on drift

      Build a cloud-based calibration registry that tracks the calibration status of every piece of hardware in every provider's setup — issuing alerts when calibration drifts outside acceptable tolerances and requiring re-calibration verification before the next diagnostic session can be recorded as valid.

    • Acoustic environment qualification check

      Room noise levels verified before each session

      Implement a pre-session acoustic environment qualification check using the headset's measurement microphone — assessing ambient noise level, reverberation characteristics, and sound isolation of the room, and flagging sessions where the environment falls below the minimum acoustic standard required for valid auditory training.

    • Diagnostic data quality improves because every session's hardware characteristics are verified and recorded — the normative database is no longer confounded by unquantified equipment variation across providers.
    • The cloud calibration registry gives APD Medical visibility into which providers are operating with out-of-specification equipment, enabling proactive maintenance rather than retrospective data quality review.
    • The acoustic environment qualification creates a feedback loop that trains providers to select appropriate therapy environments — improving session quality across the network over time without requiring centralised enforcement.
  • Digital Lab

    Provider Network Digital Operating System

    We build a digital operating system for the APD Medical provider network — automated certification tracking, AI-driven competency monitoring based on diagnostic accuracy patterns, and patient referral management — transforming the network from a collection of independent practitioners into a data-driven clinical ecosystem where patient outcomes drive referrals and provider development.

    • Provider competency monitoring dashboard

      Diagnostic accuracy tracked per provider over time

      Build a provider performance dashboard that tracks diagnostic accuracy patterns, session completion rates, and patient outcome trajectories for each provider — identifying which providers are most effective at which patient types and surfacing skill gaps that targeted training interventions can address.

    • Automated certification and credential tracking

      Provider certifications tracked and expiry-alerted automatically

      Implement an automated certification tracking system for provider credentials, training completions, and annual competency assessments — eliminating the manual tracking that currently allows expired certifications to go undetected and creating an auditable record for regulatory compliance.

    • AI-assisted patient referral routing

      Patients routed to optimal providers based on outcome data

      Build a referral routing engine that matches new patients to providers based on the provider's demonstrated accuracy with similar patient profiles — moving referrals from a reputation-based model to a data-driven model that improves patient outcomes by matching each patient to the provider most effective for their specific presentation.

    • Patient outcomes improve because referrals are routed based on demonstrated provider effectiveness data rather than geographic convenience or historical relationship — each patient is more likely to reach the provider who is most effective for their specific auditory processing profile.
    • The certification tracking system reduces the regulatory and liability risk of operating with expired credentials — an automated alert before expiry is substantially more reliable than a provider's personal calendar management.
    • APD Medical's competitive advantage in provider quality becomes visible and defensible — the outcome data that the platform generates is a moat that competitors cannot replicate without building the same longitudinal dataset.
  • Enterprise AI

    FHIR-Compliant Healthcare Integration and SaMD Certification Platform

    We architect and implement the FHIR-compliant integration layer and quality management infrastructure required for Software as a Medical Device certification under EU MDR — enabling the hospital EHR connectivity, insurance reimbursement, and clinical care pathway integration that the current pedagogical classification prevents.

    • FHIR-compliant API gateway for Neuroflow platform

      Hospital EHR systems can exchange data with Neuroflow

      Deploy a FHIR-compliant API gateway that exposes Neuroflow diagnostic results, therapy session summaries, and patient progress data through standardised FHIR resources — enabling bidirectional integration with hospital EHR systems and primary care clinical workflows.

    • Clinical validation study design and data platform

      Clinical evidence generated for MDR technical file

      Design and implement the clinical validation study architecture — patient recruitment tracking, outcome measurement protocols, and statistical analysis pipeline — to generate the clinical evidence that the EU MDR technical documentation requires for SaMD certification.

    • Post-market surveillance infrastructure

      Real-time safety monitoring after MDR certification

      Build the post-market surveillance system required for an active medical device — adverse event tracking, complaint management workflows, and periodic safety update report generation — ensuring that the platform continuously meets the safety monitoring obligations that MDR certification requires.

    • The hospital integration enables the clinical care pathway revenue stream — Neuroflow becomes a prescribed, reimbursed digital therapeutic rather than a self-pay educational tool, dramatically expanding the addressable patient population.
    • The MDR certification differentiates APD Medical from the international NeuroFlow competitor that has not achieved medical device classification — CE marking is a substantive competitive moat that the Polish platform can establish before international competitors enter the neuro-audiology specific market.
    • The post-market surveillance data becomes a continuous improvement engine — every safety signal and adverse event is tracked and analysed, providing the evidence base for future algorithm improvements and MDR post-market surveillance reports.
  • Enterprise AI

    Predictive Auditory Analytics Engine

    We develop a predictive diagnostic engine using machine learning models trained on the longitudinal Neuroflow platform dataset — identifying sub-clinical auditory processing patterns that precede disorder manifestation, enabling earlier intervention and personalised therapy intensity calibration for each patient's specific developmental trajectory.

    • Longitudinal outcome trajectory modelling

      Each patient's therapy response predicted from history

      Build predictive models that analyse each patient's historical diagnostic data, therapy session responses, and outcome trajectories to predict how the patient's auditory processing capabilities are likely to develop — enabling therapy intensity and frequency to be calibrated to the individual patient's predicted trajectory rather than to population averages.

    • Sub-clinical pattern detection for early intervention

      Risk indicators flagged before disorder becomes clinical

      Implement a sub-clinical pattern detection system that identifies early markers of auditory processing difficulty in children before referral for formal assessment — enabling the early intervention window that has the highest therapeutic efficacy.

    • Provider decision support dashboard

      Therapy recommendations generated from patient data

      Build a provider-facing decision support dashboard that presents the predictive model's assessment alongside the provider's own clinical evaluation — giving providers the AI-augmented insight that helps them make more accurate diagnoses and more effective therapy recommendations without replacing clinical judgement.

    • Children who would otherwise be assessed only after significant developmental delay are identified earlier — the early intervention window that has the highest therapeutic efficacy is used rather than missed.
    • Therapy personalisation improves because each patient's predicted trajectory is used to calibrate intensity — the platform's fundamental competitive advantage over one-size-fits-all auditory training is amplified by AI-driven personalisation.
    • The longitudinal dataset that the predictive engine requires becomes more valuable as it grows — every completed therapy case improves the model's accuracy, creating an increasing returns dynamic where the platform with the most data delivers the best outcomes.
  • Digital Lab

    Environmental Monitoring for Therapy Session Validity

    We implement a sensor ecosystem integrated with the Neuroflow therapy platform that monitors session acoustic environment quality and patient biometric state — automatically qualifying whether each session meets the conditions required for valid auditory stimulus delivery and flagging or pausing sessions where environmental conditions compromise therapeutic integrity.

    • Ambient noise monitoring during therapy sessions

      Background noise measured continuously during every session

      Integrate ambient noise sensing using the diagnostic headset's built-in microphone — continuously monitoring background noise levels during therapy sessions and automatically flagging sessions where ambient noise exceeds the acoustic threshold required for valid stimulus delivery, with the environmental quality record stored alongside the session data.

    • Biometric feedback integration for patient engagement

      Heart rate and attention indicators monitored during sessions

      Implement biometric wearable integration — heart rate and electrodermal activity sensors — to monitor patient engagement and stress levels during therapy sessions, providing both a real-time feedback signal for therapy adaptation and a data channel for outcome analysis.

    • Session validity score in the patient record

      Every session rated for environmental and biometric quality

      Build a session validity scoring system that rates each completed therapy session on acoustic environment quality, patient biometric engagement, and stimulus delivery verification — providing a data quality filter for the AI model training data and giving clinicians a reliable signal about which sessions produced clinically useful results.

    • AI model training data quality improves because sessions with compromised acoustic environments are flagged and excluded — the diagnostic algorithms are trained on high-quality data that actually reflects what the patient heard, not what the platform assumes they heard.
    • Providers receive objective evidence about the acoustic quality of their practice environments — this feedback drives improvement in the physical spaces where therapy is delivered without requiring APD Medical to audit every provider location.
    • The session validity score creates a defensible evidence base for therapy efficacy — when outcomes are questioned by insurers, clinicians, or regulators, APD Medical can demonstrate that the therapy was delivered under valid conditions.

Digital maturity: today and target

Scored out of 100 across six dimensions. The target is what APD Medical Sp. z o.o.'s own published ambition implies — not a perfect score.

Source: A4BEE analysis of public sources
Data Integration 45 → 85
Patient diagnostic data from the provider network sits in disconnected local systems and the Neuroflow platform — there is no unified patient index that connects provider assessments, platform therapy records, and home session data. The longitudinal data required for predictive analytics is fragmented across systems that do not communicate.
IT/OT Convergence 30 → 80
The Neuroflow platform is a sophisticated web application, but there is no hardware-in-the-loop calibration verification for the consumer-grade headphones and audio equipment used across the provider network. The acoustic environment in which sessions are conducted is not monitored. The physical delivery of auditory therapy is not digitised in a way that enables quality control.
Predictive Analytics 35 → 85
The platform currently makes normative comparisons — comparing a patient against population reference data — rather than predictions. The longitudinal dataset exists in aggregate, but the ML infrastructure required to identify sub-clinical patterns, predict therapy trajectories, and personalise interventions does not yet exist.
Regulatory Readiness 25 → 75
Neuroflow ATS is classified as a pedagogical tool. The quality management system, clinical validation data, post-market surveillance infrastructure, and FHIR-compliant architecture required for EU MDR SaMD certification have not been built. The path from current status to MDR certification requires significant investment and regulatory expertise.
Ecosystem Integration 20 → 70
The provider network does not share a common digital infrastructure — certification tracking is manual, referral routing is reputation-based, and equipment calibration is not monitored centrally. The patient data from provider assessments is not connected to the platform's therapy records in a unified longitudinal view.
Cybersecurity Posture 55 → 85
Patient health data — including children's developmental and auditory assessment data — flows across provider systems, the central platform, and home devices. The current data governance architecture does not include the security controls required for a medical device under MDR, and the platform's data protection practices have not been audited against MDR cybersecurity requirements.

Check this yourself

Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.

Think we've read this right?

Talk to us

Related reading

This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with APD Medical Sp. z o.o., and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].